In this week's Homerun Slides, the addition of liraglutide to insulin degludec.

Diabetes in Control publisher Steve Freed met with Dr. Larry Hirsch, Vice President of Global Medical Affairs for the Diabetes Care Business at BD at the 2015 ADA Sessions in Boston. This week, Dr. Hirsch discusses the unexplainable highs, known as silent occlusions, that some patients using pumps may experience.

‘Brittle’ diabetes is a controversial and fortunately uncommon disorder, described especially in the UK and USA, usually occurring in young women, with onset at puberty, and defined as a patient whose life is ‘constantly disrupted by episodes of hypo- or hyperglycemia, whatever their cause.’

Male, 72 years of age, type 2 diabetes, overweight secondary to binge eating disorder. Taking glipizide 20mg daily and metformin 1,000mg twice daily. Hypoglycemic unawareness. Not regularly checking glucose. Recent A1C 6.8%.